Fintel reports that on January 30, 2025, Stifel upgraded their outlook for Edwards Lifesciences (NYSE:EW) from Hold to Buy.

Approximately 9,000 Illinois residents are eligible to claim money from a settlement with investor services company Vanguard after the company was found not to have disclosed the tax implications of a ...